[1]
2025. Clinical and laboratory predictors of therapeutic response to Tocilizumab in rheumatoid arthritis. One Health & Risk Management . 6, 3 (Sep. 2025), 44–53. DOI:https://doi.org/10.38045/ohrm.2025.3.04.